AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 235 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,134,626 | +6.9% | 631,487 | +9.9% | 0.71% | +20.7% |
| Q2 2023 | $41,273,725 | +51.6% | 574,363 | +30.1% | 0.59% | +49.1% |
| Q1 2023 | $27,222,468 | -19.2% | 441,350 | +1.1% | 0.40% | -11.6% |
| Q4 2022 | $33,679,431 | +52.0% | 436,658 | -12.1% | 0.45% | +40.6% |
| Q3 2022 | $22,155,000 | -29.2% | 496,524 | -39.2% | 0.32% | -28.1% |
| Q2 2022 | $31,297,000 | +5.1% | 817,141 | +13.6% | 0.44% | +27.7% |
| Q1 2022 | $29,779,000 | +20.9% | 719,482 | +10.4% | 0.35% | +36.2% |
| Q4 2021 | $24,630,000 | -0.8% | 651,937 | -13.4% | 0.25% | +0.8% |
| Q3 2021 | $24,817,000 | +4.5% | 752,945 | +113.9% | 0.25% | +8.6% |
| Q2 2021 | $23,747,000 | – | 352,021 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |